Zhu, Tong
Pfizer (United States)
2 papers on CoChatORCID 0000-0003-4931-656X
Most cited papers
- Verified
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6
Toogood, P. L., Harvey, P. J., Repine, J. T., Sheehan, D. J., VanderWel, S. N., Zhou, H., Keller, P. R., McNamara, D. J., Sherry, D., Zhu, T., et al. (2005) · Journal of Medicinal Chemistry
Heterocyclic Compound Synthesis and BioactivityAdvanced Breast Cancer Therapies
Cited by 513
- Verified
Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family
Smaill, J. B., Gonzales, A. J., Spicer, J. A., Lee, H., Reed, J. E., Sexton, K., Althaus, I. W., Zhu, T., Black, S. L., Blaser, A., et al. (2016) · Journal of Medicinal Chemistry
HER2/EGFR in Cancer ResearchQuinazolinone synthesis and applications
Cited by 63
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free